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Abstract
Recently, zinc emerged as an important signaling molecule, activating intracellular
pathways and regulating cell fate, although our knowledge remains incomplete. Zinc
is  required in  many enzymatic  and metabolic  pathways,  playing roles  as  enzyme
cofactors. In normal cell physiology, optimal zinc availability is essential for regular
growth and proliferation. Zinc accumulation has varied effects: from stimulation to
inhibition of cell growth, depending on type. There is evidence that zinc is capable of
inducing apoptosis in some cancers, while others proved that zinc may act as apopto‐
sis activator depending on the dose and cell type. Upregulation of telomerase in most
cancer tissues is considered to be responsible for unlimited proliferation of cancer cells,
and in some cell lines, it was induced by Zn. These suggest that Zn is highly involved
in cell cycle and metabolism; whether it goes to the survival or the cancer pathway
depends on the concentration and the cell type involved. Nevertheless, the conclusion
is that Zn is not just another trace element; but a vital one and further studies are needed
to elucidate the mechanisms involved in cancer and metastatic  spread in order to
identify potential therapies.
Keywords: functions of zinc, zinc deficiency, high concentration of zinc, cancer, zinc,
lung cancer, deficiency, homeostasis
1. Introduction
Zinc is one of the most important trace elements in the body. It has a catalytic/regulatory role
in many enzymes, maintains the structural integrity of different proteins, and modulates
protein-protein interactions. At the cellular level, zinc is essential for cell proliferation and
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
survival, contributes to genomic stability and antioxidant defense, which highlights its crucial
role in aging and age-dependent degenerative diseases.  Zinc is  indispensable for proper
immune function, its insufficiency may exacerbate immune-senescence, and zinc supplemen‐
tation is beneficial to immune responses in the elderly [1]. In the intracellular environment,
zinc interacts with signal transducers implicated in immune response and influences both the
structural stability and function of immunologically relevant transcription factors [2]. Zinc is
needed for DNA synthesis, RNA transcription, cell division, and cell activation. Program‐
med cell death (apoptosis) is potentiated in the absence of adequate levels of zinc under
physiological conditions [3].
During the past four decades, a spectrum of zinc clinical deficiencies in human subjects has
emerged. On one hand, the manifestations of zinc deficiency (ZD) may be severe, and on the
other end of the spectrum, ZD may be mild or marginal [3]. Micronutrient deficiencies are an
important and global public health problem. In Mexico, the first comprehensive picture of the
frequency and distribution of micronutrient deficiencies was presented by the Mexican
National Nutrition Survey of 1999. Zinc deficiency was the second most common micronu‐
trient deficiency; 34% of which was found in infants [4]. Several studies have now confirmed
that ZD is fairly prevalent in developing countries, affecting nearly two billion subjects and
that growth retardation commonly observed in these countries may indeed be due to ZD [5].
Increased prevalence of obstructive lung disorders and lung cancer is associated with low
dietary Zinc (Zn) intake and thought to be due, at least in part, to protective effects of Zn against
cadmium, which is toxic and accumulates in alveolar macrophages (AM). Among the actions
of Zn ions on the immune system are its effects on phagocytic cells. Hamon and colleagues [6]
suggested links between lung injury, impaired phagocytosis, and Zn deficiency. In the
bloodstream, zinc insufficiency may also contribute to cardiovascular risk via its association
with reduced antioxidant capacity [7], endothelial dysfunction [8], arterial wall stiffness, and
increased systolic blood pressure [9, 10].
The use of zinc as a nutritional supplement has become very common in many countries.
However, adverse effects of high doses of zinc supplement on immunologic functions have
not been clearly defined. Some studies from animal models show that high dietary zinc
increased the functions of T lymphocytes and macrophages [11, 12]. Other studies reported a
decrease in lymphocyte stimulation response, chemotaxis and bacterial phagocytosis of
polymorphonuclear leukocytes, and monocyte function and neutropenia by high oral intake
of zinc [13, 14].
2. Zinc, extracellular matrix, and cancer
Zinc was demonstrated to have the ability to neutralize free radicals protecting the body from
harmful effects, immune disorders, and increased risk of cancer [15]; therefore, the deficien‐
cy of zinc may increase oxidative stress [16, 17]. Importantly, an increase of oxidative and
nitrosative stress and inflammation in rat lung, in a stage of marginal zinc deficiency, was
found [16, 18].
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Cell-cell and cell-extracellular matrix interactions are essential in the development and
maintenance of normal tissue cytoarchitecture and play an important role in the develop‐
ment and progression of many types of cancer [19]. Simultaneously, with the changes causing
the immortalization of epithelial cells, there is a gradual evolution of the tumor microenvir‐
onment [19].
The extracellular matrix (ECM) represents a very complex network of structurally, mechani‐
cally, and biochemically heterogeneous components [20] including: collagen, elastin, fibrillin,
fibulin, glycoproteins, and integrin receptors of ECM components [19, 21]. The systems that
regulate deposition and stability of the ECM also include chaperones and enzymes that
catalyze the post-translational processing of ECM components, as well as systems that
destabilize and degrade the ECM to facilitate its renewal [20, 21].
It is known that matrix metalloproteinases (MMPs) are a family of zinc dependent endopep‐
tidases which main function is to degrade and deposit structural proteins within the ECM. The
production of MMPs is stimulated by factors such as oxidative stress, growth factors, and
inflammation which lead to its up or downregulation with subsequent ECM remodeling [22].
Normally, excess MMPs activation is controlled by tissue inhibitors of metalloproteinases
(TIMPs). MMPs and TIMPs imbalance has been implicated in multiple diseases [22]. Recent
studies have demonstrated that ECM and basement membrane degradation by MMPs play an
important role in tumorigenesis by modulating cell proliferation, apoptosis, and host im‐
mune surveillance, tumor invasion and metastasis [23]. In addition, MMP-9 acts as an
important oncogene, thereby improving the invasiveness of cancer cells. It has been suggest‐
ed that a high level of MMP-9 confers a poor prognosis in various cancers [24]. On the other
hand, MMP2 (gelatinase A) has attracted particular interest in neoplasias, since it degrades
type IV collagen, a major component of basement membrane undergoing destruction at an
early stage of the invasive process [25].
It is generally accepted that a fundamental process for distant metastasis formation compris‐
es epithelial-mesenchymal transition (EMT), during which tumor cells lose their epithelial
properties and acquire a fibroblast-like phenotype; as a consequence, reduced intercellular
adhesion, enhanced invasiveness, and increased apoptotic resistance of cells [26, 27]. In the
early stages of tumor, several signaling pathways are activated, such as growth factors and
zinc-finger transcription factors including Snail [26, 28]. In fact, Snail-1 has been shown to be
crucial during cancer progression and metastasis. In colon cancer patients, enhanced levels of
Snail1 are usually associated with poor clinical outcome [26, 29]. Recent studies in Snail-1
deficient mouse embryos support the idea that transcriptional repression of E-cadherin
(cellular adhesion molecules) is associated with Snail-1 activity [26].
Marginal ZD was also associated with oxidative stress and inflammation in both mammary
gland ductal epithelium and adipocyte-rich stromal. Excess of collagen directly inhibits
mammary gland expansion and has major implications for breast disease risk [30]. Zinc-
dependent enzyme MMP2 activity, a critical protein for ductal elongation and infiltration into
the mammary fat pad, was also modified in ZD mice mammary glands [30].
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Heat shock proteins are chaperones that play a pivotal role in cells survival under stressful
conditions. Under normal conditions, Heat shock protein 27(Hsp27) is weakly expressed in
cells; however, once stress occurs, Hsp27 expression increases, exerting an anti-oxidative
damage function [31]. We analyzed the effect of Zn deficiency on the expression of cytopro‐
tective factors (Hsp27 and Hsp70i) where both chaperones increased and are consistently
associated with cellular stress and inflammation in lung [32, 33]. Likewise, Hsp70 has a role
in iNOS induction [16, 31, 33]. In addition, proliferating cell nuclear antigen (PCNA) expres‐
sion was increased in the ZD group [31, 34]. Qin and colleagues [31] demonstrated a possi‐
ble association between PCNA and Hsp27 expression in retinoblastoma tumor. There is a lot
of evidence that PCNA expression can be used as an index for evaluating malignant tumor
cells proliferation, as well as the malignant potential and prognosis of a tumor [31, 35, 36].
Molecular mechanisms that define the pathological and physiological activities of EMT in
distinct cellular contexts likely intersect. Zinc could act as trigger factor of events cascade in
the ECM. Therefore, in order to understand some of the pathological mechanisms involved in
cancer and metastasis, it would be necessary for more studies.
3. Zinc and apoptosis in lung cancer cells: excess or default?
Zinc plays a role in several intracellular signaling pathways, and its deregulation is present in
various cancers. Levels of zinc in serum and malignant tissues of patients with various types
of cancer are abnormal, supporting the involvement of zinc in cancer development. Imba‐
lance of zinc transporters cause intracellular and serum zinc levels alteration. Patients with
lung, breast, liver, and prostate cancer exhibit zinc deregulation in a meta-analysis per‐
formed in [37]. Zinc level decreases in lung cancer, but it is unclear whether hypozincaemia is
a consequence of tumor, chronic stress, or a combination of both effects [38]. Stress, infection,
or chronic diseases lead to redistribution of zinc between body compartments, and thus reduce
zincaemia [39].
Zinc is required for both normal cell survival and for cell death via its role in apoptosis, which
is strongly regulated. Its deregulation is central to the pathogenesis of a number of diseases,
including cancer. As such, the factors like zinc that regulates the execution phases of apopto‐
sis are of great interest as potential therapies. Free zinc ion does not only act as an inhibitor
but also may act as an activator of apoptosis depending on dose and cell type. Franklin et al.
[40] reviewed the effects of zinc on the regulation of apoptosis in malignant cells, because it is
reported to both induce apoptosis in some cancers and to protect other cancer cells against
apoptosis induced by other factors. They studied prostate, breast, liver, pancreas, and ovarian
cancer finding that zinc is an apoptogenic agent in ovarian epithelial cells, in breast epithe‐
lial cells, and in prostate cells [40].
It is well known that lung cancer is the leading cause of cancer-related deaths in both men and
women. Lung cancer is subdivided into two types based on cell type and pathology: small-cell
lung cancers and non-small-cell lung cancers (NSCLCs), of which approximately 85% are
NSCLCs [41]. At the advanced stages, taxane chemotherapy regimens are commonly used for
the treatment of NSCLCs as first-line options, but the therapeutics results are not satisfacto‐
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ry. Kocdor et al. [42] found that zinc exhibited growth inhibitory and apoptotic effects in a
dose-dependent manner, up to the IC50 concentrations for cultured lung cancer cells.
Importantly, these effects were significantly increased when zinc and docetaxel (derived from
the paclitaxel—natural compound isolated from pacific yew tree bark) were combined to treat
lung cancer. Importantly, zinc deficiency reduces paclitaxel efficacy in cultured prostate cancer
cells, whereas increased intracellular zinc concentrations sensitize prostate cancer cells to
cytotoxic agents, including paclitaxel, via inhibition of NF-κB activation [43, 44]. Therefore,
authors proposed that zinc supplementation may have growth inhibitory effects against
NSCLC cells and may increase docetaxel efficacy [42]. The semisynthetic form, docetaxel,
primarily stabilizes cytoplasmic microtubules via binding to the β-tubulin site, causing cell
cycle arrest at the G2/M phase and driving apoptosis. Therefore, the IC50 doses of docetaxel
and zinc were higher for the p53-null H1299 cells than A549 cells. Functional p53 status may
influence docetaxel and zinc-induced cytotoxicity. PTEN-PI3K-Akt-Bax signaling cascade is
involved in the therapeutic effect of combined radiation/paclitaxel treatment in NSCLC
without p53 expression [45].
John et al. [46] proposed that zinc depletion induces cell death via apoptosis (or necrosis if
apoptotic pathways are blocked), while sufficient zinc levels allows maintenance of cell
survival pathways such as autophagy and regulation of reactive oxygen species. Although in
the results shown by meta-analysis zinc tissue levels are low in lung cancer [37, 38], two older
studies demonstrated the contrary: they exhibit elevated zinc levels when compared with the
corresponding normal tissues [47, 48]. Interestingly, while data of zinc levels in tumor tissue
is limited, it has been widely recognized that ZIP is upregulated in most cancers, thereby
indicating increased zinc concentrations in tumor majority [46]. Additionally, peripheral tissue
surrounding lung metastasis has higher zinc content than the corresponding normal tissue or
the tumor tissue itself [47]. Consequently, zinc levels regulation to promote immune cells
survival and tumor apoptosis are in order. Likewise adjustments in zinc homeostasis may be
a contributing factor in genetic alterations (ZNT, ZIP, metallothionein, etc.) or environmen‐
tal causes (nutritional status, exposure to zinc, microbial control) playing a role in the genesis
and/or maintenance of cancer [46].
Lung cancer chemotherapy treatments itself do not produce satisfactory results; however,
apoptogenic effect of zinc increased docetaxel therapy efficacy against NSCLC, achieving good
results. Zinc transporters are upregulated in lung cancer, but more data are needed to clarify
zinc tissue tumor values and its role in the triggering and progress of apoptosis to finally found
a successful therapy facing this scourge.
4. Zinc and telomerase
A telomere is a repetitive sequence of DNA that protects the ends of linear chromosomes from
deterioration and repair activity [49]. Mammalian telomeres consist of repetitive TTAGGG
sequences that are crucial to formation of the capping structures, which are bound by telomere-
binding factors called shelterin [50]. The shelterin complex is a six subunit complex com‐
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posed of directly binding proteins TRF1, TRF2, and POT16 and their associated proteins Rap1,
TPP1, and TIN2 [51].
Due to the inability of DNA polymerase to replicate the 5′ end of the lagging strand, the length
of telomeres is shortened progressively with each cell division, which eventually leads to
cellular senescence when the telomere length is reduced beyond the critical level [52]. It is
believed that the maintenance of telomeres is essential for the immortality of cancer cells.
Telomeres are maintained by a specialized reverse transcriptase, the ribonucleoprotein
telomerase, which is composed of a ubiquitously expressed RNA subunit, human telomer‐
ase RNA component [hTERC; 53], and a protein catalytic subunit, human telomerase reverse
transcriptase (hTERT), the expression of which is highly regulated [54].
Zn deficiency is known to suppress the proliferation of tumor cells [55], suggesting that Zn
has an important role in cell proliferation. The involvement of Zn in the proliferation of
lymphocytes and other non-cancer cells also has been documented [7]. But other evidence
shows that tumor size has a reverse relationship with zinc amount [56, 57].
In 2000, Nemoto et al. [58] studied how zinc modulates telomerase activity, showing that
treatment with 100 uM Zn enhanced telomerase activity in renal cell carcinoma (NRC-12) and
human prostatic cancer (DU145) cells. This enhancing effect of Zn suggests that it may not be
caused by cytotoxicity but rather by some biological events such as induction of Zn/binding
proteins or activation of transcription factors containing Zn-finger motifs. Based on that,
Zarghami et al. [59] studied the relation between Zn plasma and telomerase activity in bladder
cancer patients. Nevertheless, they only found a significant relationship between Zn and
Telomerase activity in the female patients, where the cancerous patients presented less Zn
concentrations than the control patients, with elevated enzyme activity, consistent with the
findings of Whelan et al. [60]. The study of Prasad et al. [61] also showed that patients with
head and neck cancer presenting bigger tumors had zinc deficiency as well [61]. Similar results
were found in lung cancer patients [62]. Therefore, there are paradoxical results regarding zinc
levels and its effect on cancer.
More recently, a new embryonic stem cell marker was discovered, zinc finger and SCAN
domain containing four genes (Zscan4), which has a key function in genomic stability by
regulating telomere elongation, and might also have a fundamental role in the mechanism
controlling telomere length regulation [63]. Zscan was also found to promote telomere
elongation during reprogramming, but it is not associated with increased telomerase activi‐
ty [64]. It has been shown that overexpression of Zscan4 rescues cell proliferation and causes
rapid telomere extension [64]. In 2014, Lee and Gollahon [65] showed that Zscan4 binds directly
to the shelterin complex member Rap1. Apparently, the binding between Zscan4 and Rap1
may be required for disrupting telomere protection dissociation of the t-loop to control
telomere length in telomere biology of cancer cells.
Another zinc-finger protein involved in cell differentiation, senescence, and apoptosis is
Zfp637. It belongs to the Kruppel-like protein family and comprises six consecutively typical
and one atypical C2H2 zinc-finger motifs. It has been reported that Zfp637 is located in nucleus
and behaves as a repression regulator in myogenic cellular differentiation by promoting
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mTERT expression [66]. Recently, in [67], it was provided the first mechanism through which
Zfp637 protects cells against oxidative stress-induced premature senescence. Zfp637 binds to
the mTERT promoter and transcriptionally activates mTERT. mTERT expression maintains
telomerase activity and telomere length and promotes cell proliferation. On the other hand,
the oxidative stress-triggered downregulation of Zfp637 results in depressed binding of Zfp637
to the mTERT promoter, leading to reduced levels of mTERT-dependent telomerase activity
and accelerated telomere shortening and cellular senescence, what can be reverted by
overexpression of Zfp637 [67].
All these studies show that several proteins involved in the activity of telomerase have Zn-
finger motifs, indirectly suggesting the involvement of this ion in cancer outcome. Unfortu‐
nately, more studies need to be done in order to assure if Zn presence or deficiency the
responsible for cancer onset.
5. Conclusion
The aim of this review was to look through the state-of-the-art concerning the zinc homeosta‐
sis and cancer. Zn microenvironment may play a key role in oxidative stress, apoptosis, and/or
cell signaling alterations which influences the behavior of malignant cancer cells. In fact, the
study of cancer biology has mainly focused on malignant epithelial cancer cells, although
tumors also contain a stromal compartment, composed by different type of cells and also
includes various types of macromolecules comprising the extracellular matrix. Following this
rationale, several hundred zinc supplementation studies have been conducted, investigating
the effects of zinc on cancer, often with contradictory results. The mechanisms responsible for
Zn accumulation and the consequence of Zn dysregulation are poorly understood, and mostly
dependent of the type of cell or tissue compromised. For this reason, further studies are needed
to elucidate the mechanism of this protection.
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